Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy
Support Us on #GivingTuesday
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218
Two Clinical Studies on Pitolisant Published
Tell the FDA that People with Narcolepsy Need Access to CNS Stimulants
Meet #TeamNarcolepsy
